These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20437569)

  • 1. HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction.
    Ramagopalan SV; Dyment DA; Giovannoni G; Sadovnick AD; Ebers GC
    Ann Neurol; 2010 May; 67(5):694-5. PubMed ID: 20437569
    [No Abstract]   [Full Text] [Related]  

  • 2. Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction.
    van der Mei IA; Ponsonby AL; Taylor BV; Stankovich J; Dickinson JL; Foote S; Kemp A; Dwyer T
    Ann Neurol; 2010 Feb; 67(2):261-5. PubMed ID: 20225292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
    J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV; Link J; Byrnes JK; Dyment DA; Giovannoni G; Hintzen RQ; Sundqvist E; Kockum I; Smestad C; Lie BA; Harbo HF; Padyukov L; Alfredsson L; Olsson T; Sadovnick AD; Hillert J; Ebers GC
    Neurology; 2009 Dec; 73(24):2107-11. PubMed ID: 20018638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS.
    Fontaine B; Barcellos LF
    Neurology; 2008 Jan; 70(2):97-8. PubMed ID: 18180438
    [No Abstract]   [Full Text] [Related]  

  • 11. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
    Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
    J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
    Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
    Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.